Related Experiment Video
Updated: Oct 6, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
Published on: September 20, 2019
Age-based exclusions in clinical trials: A review and new perspectives
Diep Nguyen1, Grace Mika2, Anh Ninh2
1Department of Computer Science, William & Mary, Williamsburg, VA, USA.
Background:
Despite elderly populations having a greater risk of being diagnosed with serious medical conditions, there has been limited clinical testing conducted on geriatric patients. By analyzing cancer, cardiovascular diseases, and type 2 diabetes data from ClinicalTrials.gov, we investigate two factors that may have significant impact on the exclusion of elderly patients from clinical trials.
Methods:
We examine age exclusion across phases and funder types and demonstrate the extent of these exclusions over all interventional studies that commenced enrollment on or after January 2010 to Oct 2021.
Results:
Cancer trials have the lowest percentage of age capped enrollment, with 22.18%, 24.13%, and 32.77% of the studies listing an upper age limit in Phases 1, 2, and 3, respectively. In comparison, cardiovascular disease trials are age capped in 51.32%, 39.9%, and 34.94% of trials, and type 2 diabetes capped in 90.3%, 74.42%, and 36.75% of trials in Phases 1, 2, and 3 respectively. Our result shows no significant changes in the percentage of trials with upper age limits pre- and post- NIH Inclusion Across the Lifespan Policy.
Conclusion:
Our analysis reveals cancer trials were the most age-inclusive. Further, NIH-funded trials have historically set fewer age caps compared to those whose funding has come from non-NIH sources, which provides optimism that inclusivity can be feasible for all trials.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
05:16Characterizing Exon Skipping Efficiency in DMD Patient Samples in Clinical Trials of Antisense Oligonucleotides
Published on: May 7, 2020
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Bioavailability Study Design: Healthy Subjects Versus Patients
Pharmacodynamics in Geriatric Patients: Effects of Age